StocksHealthcareVCYT

VCYT

VERACYTE, INC.
NasdaqResearch view
Healthcare · Services-Medical Laboratories · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$3.2B
Enterprise Value$2.8B
Income$66.4M
Sales$517.1M
Book/sh$16.29
Cash/sh$4.53
Dividend TTM
Payout
Employees
IPO
Quick Ratio7.81
Current Ratio8.15
Debt/Eq
EPS (ttm)$0.82
EPS this Y164.5%
EPS past 3/5Y
Sales past 3/5Y20.4%
EPS Y/Y TTM164.5%
Sales Y/Y TTM16.0%
Shs Outstand80.39M
ROA4.7%
ROE5.1%
ROIC5.9%
Gross Margin70.1%
Oper. Margin11.2%
Profit Margin12.8%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$219.5M
2021
$296.5M
2022
$361.1M
2023
$445.8M
2024
$517.1M
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%70%11%13%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Capital-light: capex is $9.7M against $136.3M operating cash
$136.3MOperating CF$9.7M− Capex$126.6MFree CF
COMMUNITY · $VCYT0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.